link ae888

Human trials of third homegrown COVID-19 vaccine to begin in March

A third COVID-19 vaccine developed by Vietnam is scheduled to be tested on humans at the end of March, the Ministry of Health said on January 19.
Human trials of third homegrown COVID-19 vaccine to begin in March ảnh 1The highest dose, 75mcg, of Nanocovax was given to three volunteers in Hanoi on January 12. (Photo: MoH)
Hanoi (VNA) – A third COVID-19 vaccinedeveloped by Vietnam is scheduled to be tested on humans at the end of March,the Ministry of Health said on January 19.

The vaccine is developed by Vaccine and BiologicalProduction No. 1 (VABIOTECH). It is one of the four companies that are developingCOVID-19 vaccines in Vietnam, along with the Institute of Vaccines and MedicalBiologicals (IVAC), the Centre for Research and Production of Vaccines andBiologicals (POLYVAC), and Nanogen Pharmaceutical Biotechnology (NANOGEN).

Nanocovax by NANOGEN is Vietnam’s first candidatevaccine against the novel coronavirus SARS-CoV-2 to reach the human trialstage.

The highest dose, 75mcg, of Nanocovax was given tothree volunteers in Hanoi on January 12.

The Nha Trang-based IVAC has also been authorised tocarry out human clinical tests for its Covivac.

According to Associate Professor Dr Chu Van Men,Director of the Military Medical University’s Centre for Clinical Trials andBioequivalence, Vietnam expects to collect all necessary data on clinicaltesting by the end of 2021 before it can consider mass vaccination./.


VNA

See more

Assoc. Prof. Dr Nguyen Viet Nhung, Dean of Medicine at University of Medicine and Pharmacy, Vietnam National University (VNU) Hanoi, speaks online on Vietnam’s digital transformation strategy in medical education. (Photo: VNA)

𓃲 Forum spotlights AI and digital innovation in healthcare

To achieve its goal of becoming a developed nation by 2045, Vietnam is prioritising the integration of AI and digital tools into the training of future doctors, said Assoc. Prof. Dr. Nguyen Viet Nhung, Dean of Medicine at University of Medicine and Pharmacy, Vietnam National University (VNU) Hanoi.
A banner on the side of a car urges people to quit smoking for their own health and that of their loved ones (Photo: VNA)

🙈 Sharp tobacco tax hike urged to safeguard youths, community health

A 2023 report by the Vietnam Health Economics Association estimated that the total cost of tobacco-related healthcare and economic losses reached 108 trillion VND (4.14 billion USD) annually – equivalent to 1.14% of GDP and five times higher than the budget revenue generated by the tobacco industry.
{dagathomo tructiep hôm nay}|{link link link ae888}|{dá gà thomo}|{trực tiếp đá gà thomo hom nay}|{sbobet asian handicap}|